BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 26782002)

  • 1. Genetic and epigenetic abnormalities in systemic sclerosis.
    Makino T; Jinnin M
    J Dermatol; 2016 Jan; 43(1):10-8. PubMed ID: 26782002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics and systemic sclerosis.
    Altorok N; Kahaleh B
    Semin Immunopathol; 2015 Sep; 37(5):453-62. PubMed ID: 26162437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis.
    Luo Y; Wang Y; Shu Y; Lu Q; Xiao R
    Int J Biochem Cell Biol; 2015 Oct; 67():92-100. PubMed ID: 26043891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of genetics and epigenetics in the pathogenesis of systemic sclerosis.
    Broen JC; Radstake TR; Rossato M
    Nat Rev Rheumatol; 2014 Nov; 10(11):671-81. PubMed ID: 25136786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics and pathogenesis of systemic sclerosis; the ins and outs.
    Aslani S; Sobhani S; Gharibdoost F; Jamshidi A; Mahmoudi M
    Hum Immunol; 2018 Mar; 79(3):178-187. PubMed ID: 29330110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
    Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
    Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the genetics and epigenetics of systemic sclerosis.
    Angiolilli C; Marut W; van der Kroef M; Chouri E; Reedquist KA; Radstake TRDJ
    Nat Rev Rheumatol; 2018 Nov; 14(11):657-673. PubMed ID: 30305700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis: genetics and epigenetics.
    Luo Y; Wang Y; Wang Q; Xiao R; Lu Q
    J Autoimmun; 2013 Mar; 41():161-7. PubMed ID: 23415078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unfolding the pathogenesis of scleroderma through genomics and epigenomics.
    Tsou PS; Sawalha AH
    J Autoimmun; 2017 Sep; 83():73-94. PubMed ID: 28526340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics: The Future Direction in Systemic Sclerosis.
    Walczyk M; Paradowska-Gorycka A; Olesinska M
    Scand J Immunol; 2017 Dec; 86(6):427-435. PubMed ID: 28930377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Control of Scleroderma: Current Knowledge and Future Perspectives.
    Tsou PS
    Curr Rheumatol Rep; 2019 Dec; 21(12):69. PubMed ID: 31813068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable Target.
    Henderson J; Distler J; O'Reilly S
    Trends Mol Med; 2019 May; 25(5):395-411. PubMed ID: 30858032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic sclerosis. Part 2. Epigenetic factors in the pathogenesis of clinical manifestations].
    Fryc J; Midro AT; Panasiuk B; Sierakowski S
    Przegl Lek; 2015; 72(1):25-30. PubMed ID: 26076574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Epigenetic Regulation of Scleroderma and Its Clinical Application.
    Luo Y; Xiao R
    Adv Exp Med Biol; 2020; 1253():375-403. PubMed ID: 32445102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics, the holy grail in the pathogenesis of systemic sclerosis.
    Altorok N; Almeshal N; Wang Y; Kahaleh B
    Rheumatology (Oxford); 2015 Oct; 54(10):1759-70. PubMed ID: 24740406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical Link Between Epigenetics and Transcription Factors in the Induction of Autoimmunity: a Comprehensive Review.
    Wu H; Zhao M; Yoshimura A; Chang C; Lu Q
    Clin Rev Allergy Immunol; 2016 Jun; 50(3):333-44. PubMed ID: 26969025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of systemic sclerosis.
    Bossini-Castillo L; López-Isac E; Mayes MD; Martín J
    Semin Immunopathol; 2015 Sep; 37(5):443-51. PubMed ID: 26032405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential.
    Tsou PS; Varga J; O'Reilly S
    Nat Rev Rheumatol; 2021 Oct; 17(10):596-607. PubMed ID: 34480165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve?
    Jeffries MA; Sawalha AH
    Expert Rev Clin Immunol; 2015 Jan; 11(1):45-58. PubMed ID: 25534978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic modulation as a therapy in systemic sclerosis.
    O'Reilly S
    Rheumatology (Oxford); 2019 Feb; 58(2):191-196. PubMed ID: 29579252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.